NNE has a two-tier structure: the Board of Directors and NNE Management. The Board of Directors supervise the performance, management and organization of our company and are elected every year at the Annual General Meeting. They consist of two representatives from our parent company, Novo Nordisk, plus two external members and two employee representatives. NNE Management is responsible for our daily operations.

NNE Management

Jesper Kløve

Chief Executive Officer

Sofie Mørck Jarl

Chief Financial Officer & Corporate Vice President, Finance & Business Support

Steen Kristensen

Corporate Vice President, Sales & Project Execution

Jens Olesen

Vice President, Process & Facility Design

Mogens Larsson

Vice President, Automation & IT

Silas Egelund Volfing

Vice President, Human Ressources


Michael Topp

General Manager, US

Sameer Taneja

General Manager, India

Karsten Munk Knudsen

Chairman of the NNE Board since 2017

Karsten Munk Knudsen, CFO and EVP for Finance, Investor Relations & Procurement, Novo Nordisk A/S. Karsten joined Novo Nordisk in 2003 and has occupied several positions over the years within finance, both in Denmark and in the US. 1999-2003, Karsten headed up Finance in NNIT.

Birgit W. Nørgaard

Vice Chairman of the NNE Board since 2014 and member of the Board since 2011

Birgit Nørgaard has worked as a full-time Board member since 2010. Prior to this, she was CEO of Grontmij | Carl Bro A/S and COO of Grontmij NV, CEO of the Carl Bro Group 2003 – 2006 and CFO 2001 – 2003. Previously, Birgit Nørgaard held executive positions at TDC and Danisco.

Michael Hallgren

Member of the NNE board since 2018

Michael Hallgren is Senior Vice President of Diabetes Active Pharmaceutical Ingredients at Novo Nordisk A/S, which he joined in 1994. In addition to his NNE Board role, Michael is Chairman of Kalundborg Symbiosis and member of the Board of Directors at Novo Nordisk Pharmatech A/S.

Klaus Steen Mortensen

Member of the NNE Board since 2018

Klaus Steen Mortensen was the CEO for Bladt Industries A/S from 2018 to 2020 and did, prior to this, hold executive positions at Vestas from 2007 – 2018. Klaus Steen Mortensen brings in-depth knowledge of project management and efficiency improvement.

Lis Thodberg

Employee-elected member of the NNE Board since 2018

Lis Thodberg (MSc Biology) is Director for the Health, Safety & Environment department at NNE since 2013. Furthermore she is responsible for driving corporate sustainability management in NNE. 

Inés Aréizaga Esteva

Employee-elected member of the NNE Board since 2021

Inés Esteva started working in NNE in 2006 as part of the graduate program, and has grown in the organization to her current position as Manager for the Active Products department. She has worked as process lead in several major projects for customers across Europe.

Corporate governance


NNE A/S is 100% owned by Novo Nordisk A/S and is included in the Consolidated Financial Statements of Novo Nordisk A/S.